RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m6A methylation of TNFSF9 and inducing polarization of tumor-associated macrophages to M2 phenotype

This study demonstrated that RBM15 enhanced PTX resistance in TNBC by promoting m<sup>6</sup>A methylation in TNFSF9 and inducing M2 polarization of tumor-associated macrophages.

Authors

Institutions

Publication Details

Journal
Hereditas
Published
2025-08-19
DOI
https://doi.org/10.1186/s41065-025-00534-0
Citations
5
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
4.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m6A methylation of TNFSF9 and inducing polarization of tumor-associated macrophages to M2 phenotype

Yijian Chen, Jun Fu, Kun Zhang, HE Xiao-ming et al.
5 citations
Hereditas
RNA modifications and cancer
4.03
article

RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m6A methylation of TNFSF9 and inducing polarization of tumor-associated macrophages to M2 phenotype

Yijian Chen, Jun Fu, Kun Zhang, HE Xiao-ming, Chao Wei
article en
5 citations

Abstract

This study demonstrated that RBM15 enhanced PTX resistance in TNBC by promoting m<sup>6</sup>A methylation in TNFSF9 and inducing M2 polarization of tumor-associated macrophages.

HereditasVol. 162(1)
Xian Yang Central Hospital (CN)
Openalex Percentile: Top 6%
RNA modifications and cancer
4.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.